Evidence map›Paper›PMID 34295862›Full record

ArticleFrontiers in pediatrics2021

Updates on Clinical and Genetic Heterogeneity of

Niaz Muhammad Khan, Basharat Hussain, Chenqing Zheng, Ayaz Khan, Muhammad Shareef Masoud, Qingquan Gu, Linhui Qiu, Naveed Altaf Malik, Muhammad Qasim, Muhammad Tariq and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pediatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. The Impact of Genetic Factors in Ménière's Disease.International journal of molecular sciences · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Malformations of cortical development: Fetal imaging and genetics.Molecular genetics & genomic medicine · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Niaz Muhammad KhanDepartment of Bioinformatics and Biotechnology, Government College University Faisalabad, Faisalabad, Pakistan.
Basharat HussainShenzhen Key Laboratory of Biomimetic Materials and Cellular Immunomodulation, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Chenqing ZhengShenzhen Real Omics Biotech Co., Ltd., Shenzhen, China.
Ayaz KhanNational Institute for Biotechnology and Genetic Engineering (NIBGE-C), Faisalabad, Pakistan; Pakistan Institute of Engineering and Applied Sciences (PIEAS), Islamabad, Pakistan.
Muhammad Shareef MasoudDepartment of Bioinformatics and Biotechnology, Government College University Faisalabad, Faisalabad, Pakistan.
Qingquan GuShenzhen Real Omics Biotech Co., Ltd., Shenzhen, China.
Linhui QiuShenzhen Key Laboratory of Biomimetic Materials and Cellular Immunomodulation, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Naveed Altaf MalikNational Institute for Biotechnology and Genetic Engineering (NIBGE-C), Faisalabad, Pakistan; Pakistan Institute of Engineering and Applied Sciences (PIEAS), Islamabad, Pakistan.
Muhammad QasimDepartment of Bioinformatics and Biotechnology, Government College University Faisalabad, Faisalabad, Pakistan.
Muhammad TariqNational Institute for Biotechnology and Genetic Engineering (NIBGE-C), Faisalabad, Pakistan; Pakistan Institute of Engineering and Applied Sciences (PIEAS), Islamabad, Pakistan.
Junlei ChangShenzhen Key Laboratory of Biomimetic Materials and Cellular Immunomodulation, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Government College University, Faisalabad · PKLifetech Scientific (China) · CNPakistan Institute of Engineering and Applied Sciences · PKShenzhen Institutes of Advanced Technology · CNChinese Academy of Sciences · CNNational Institute for Biotechnology and Genetic Engineering · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microcephaly (MCPH) is a genetically heterogeneous disorder characterized by non-progressive intellectual disability, small head circumference, and small brain size compared with the age- and sex-matched population. MCPH manifests as an isolated condition or part of another clinical syndrome; so far, 25 genes have been linked with MCPH. Many of these genes are reported in Pakistani population, but due to a high rate of consanguinity, a significant proportion of MCPH cohort is yet to be explored. MCPH5 is the most frequently reported type, accounting for up to 68.75% alone in a genetically constrained population like Pakistan. In the current study, whole exome sequencing (WES) was performed on probands from 10 families sampled from South Waziristan and two families from rural areas of the Pakistani Punjab. Candidate variants were validated through Sanger sequencing in all available family members. Variant filtering and

Indexed as

founder effectMCPH5Pakistani populationprimary microcephalywhole exome sequencing

Identifiers

PMID34295862
PMCPMC8290066
OpenAlexW3181534384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.